Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR

Journal of Medical Microbiology

Volumn 49, Issue 6, 2000, Pages 575-581

  Becker, K ^a   Badehorn, D ^a   Deiwick, S ^a   Peters, G ^a   Fegeler, W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENOTYPE; HOSPITAL INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 0034121925     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-6-575     Document Type: Article

References (37)

1. 1. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-125.
2. 2. Odds FC. Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects. Int J Antimicrob Agents 1996; 6: 141-144.
3. 3. Ellis ME, Clink H, Ernst P et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 3-11.
4. 4. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37: 1847-1849.
5. 5. Shepp DH, Klosterman A, Siegel MS, Meyers JD. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. J Infect Dis 1985; 152: 1257-1263.
6. 6. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-421.
7. 7. Wingard JR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 1994; 19 Suppl 1: S49-S53.
8. 8. Fidel PLJ, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80-96.
9. 9. Pfaller MA. Epidemiological typing methods for mycoses. Clin Infect Dis 1992; 14 Suppl 1: S4-S10.
10. 10. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990; 18: 7213-7218.
11. 11. Williams JGK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 1990; 18: 6531-6535.
12. 12. Taylor JW, Geiser DM, Burt A, Koufopanou V. The evolutionary biology and population genetics underlying fungal strain typing. Clin Microbiol Rev 1999; 12: 126-146.
13. 13. Barnett JA, Payne RW, Yarrow D. Yeasts, characteristics and identification. Cambridge, Cambridge University Press. 1983.
14. 14. Kurtzman CP, Fell JW. The yeasts, a taxonomie study, 4th edn. Amsterdam, Elsevier. 1998.
15. 15. Ellinghaus P, Badehorn D, Blumer R, Becker K, Seedorf U. Increased efficiency of arbitrarily primed PCR by prolonged ramp times. Biotechniques 1999; 26: 626-630.
16. 16. Böttger EC. Frequent contamination of Taq polymerase with DNA [letter]. Clin Chem 1990; 36: 1258-1259.
17. 17. Rand KH, Houck H. Taq polymerase contains bacterial DNA of unknown origin. Mol Cell Probes 1990; 4: 445-450.
18. 18. Robert F, Lebreton F, Bougnoux ME et al. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 1995; 33: 2366-2371.
19. 19. Bingen EH, Weber M, Derelle J et al. Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol 1993; 31: 2589-2593.
20. 20. Woods JP, Kersulyte D, Goldman WE, Berg DE. Fast DNA isolation from Histoplasma capsulatum: methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microbiol 1993; 31: 463-464.
21. 21. Arif S, Barkham T, Power EG, Howell SA. Techniques for investigation of an apparent outbreak of infections with Candida glabrata. J Clin Microbiol 1996; 34: 2205-2209.
22. 22. Tyler KD, Wang G, Tyler SD, Johnson WM. Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol 1997; 35: 339-346.
23. 23. Ellsworth DL, Rittenhouse KD, Honeycutt RL. Artifactual variation in randomly amplified polymorphic DNA banding patterns. Biotechniques 1993; 14: 214-217.
24. 24. Meier A, Persing DH, Finken M, Böttger EC. Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol 1993; 31: 646-652.
25. 25. Caetano-Anollés G, Bassam BJ, Gresshoff PM. Primer-template interactions during DNA amplification fingerprinting with single arbitrary oligonucleotides. Mol Gen Genet 1992; 235: 157-165.
26. 26. Welsh J, McClelland M. Genomic fingerprinting using arbitrarily primed PCR and a matrix of pairwise combinations of primers. Nucleic Acids Res 1991; 19: 5275-5279.
27. 27. Lee W, Burnie JP, Matthews RC, Oppenheim B, Damani NN. Hospital outbreaks with yeasts. J Hosp Infect 1991; 18 Suppl A: 237-249.
28. 28. Khattak MN, Burnie JP, Matthews RC, Oppenheim B. Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections. J Clin Microbiol 1992; 30: 2211-2215.
29. 29. Schönian G, Tietz H-J, Thanos M, Gräser Y. [Application of molecular biological methods for daignosis and epidemiology of human fungal infections.] Anwendung molekularbiologischer Methoden für Diagnostik und Epidemiologie humaner Pilzinfektionen. Mycoses 1996; 39 Suppl 1: 73-80.
30. 30. Xu J, Vilgalys R, Mitchell TG. Lack of genetic differentiation between two geographically diverse samples of Candida albicans isolated from patients infected with human immunodeficiency virus. J Bacteriol 1999; 181: 1369-1373.
31. 31. Clemons KV, Feroze F, Holmberg K, Stevens DA. Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods. J Clin Microbiol 1997; 35: 1332-1336.
32. 32. Redkar RJ, Dubé MP, McCleskey FK, Rinaldi MG, Del Vecchio V. DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. J Clin Microbiol 1996; 34: 1677-1681.
33. 33. Dubé MP, Heseltine PNR, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994; 18: 77-82.
34. 34. Kunova A, Trupl J, Špánik S et al. Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole. Chemotherapy 1995; 41: 39-44.
35. 35. Chandrasekar PH, Gatny CM and the Bone Marrow Transplantation Team. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. J Antimicrob Chemother 1994; 33: 309-318.
36. 36. Coste T, Barale T, Reboux G et al. Prophylaxie antifungique par fluconazole: son influence sur l'augmentation de la fréquence d'isolement de Candida glabrata. Bull Soc Fr Mycol Méd 1990; 19: 151-154.
37. 37. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992; 30: 3249-3254.